RxDoctor Payments DataLook up a doctor →

Austin Hardy, PA

Physician Assistant · East Syracuse, NYNPI 1770163131

Payments from drug & device makers

$84,849in general payments, 2019–2025

Across 1,377 payments — averaging $61.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$43K
  • AbbVie$16K
  • Organon$7K
  • Pfizer$4K
  • Johnson & Johnson$2K
  • Sun Pharmaceutical Industries Inc.$2K
  • plus $12K from 19 others

What the payments were for

  • Consulting fees$15,38018%
  • Speaking & faculty fees$38,13445%
  • Travel & lodging$5,9167%
  • Food & beverage$24,49629%
  • Education$9221%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$84,849 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$103,207
Medicare patients
366
Services billed
2,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AdbryTralokinumab-Ldrm56$176,315
OtezlaApremilast33$156,993
Dupixent PenDupilumab31$116,880
Cosentyx Unoready PenSecukinumab11$79,488
VtamaTapinarof18$25,239
Clobetasol Propionate185$9,095
Ivermectin13$3,832
Tacrolimus25$3,243
Metronidazole49$3,151
Fluorouracil39$2,382
Triamcinolone Acetonide166$2,224
Ketoconazole112$1,974
Clindamycin Phosphate52$1,846
Betamethasone Dipropionate34$1,603
Tretinoin25$1,463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
LEO Pharma Inc.Adbry$42,921$176,31556 claims
AmgenOtezla$767$156,99333 claims
Dermavant Sciences, Inc.Vtama$1,437$25,23918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in East Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →